By Carmen Mirabellia, et al. Significance Since its emergence in China in December 2019, SARS-CoV-2 has caused a global pandemic. Repurposing of FDA-approved drugs is a promising strategy for identifying rapidly deployable treatments for COVID-19. Herein, we developed...
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
read more